Oroco Engages Whittle Consulting Ltd.

(TSX-V:OCO),(Boerse Frankfurt – Freiverkehr:OR6),(OTC US:ORRCF),(Other OTC:ORRCF), VANCOUVER, Canada, July 02, 2025 (GLOBE NEWSWIRE) — Oroco Resource Corp. (TSX-V: OCO; OTC: ORRCF) (“Oroco” or the “Company”) is excited to announce that it has retained Whittle Consulting Ltd., based in Melbourne, Australia, to undertake a Strategic Option Study (the “Study”) for Oroco's Santo Tomas porphyry copper project […]

Pasinex Announces 2024 Annual and 2025, Q1 Financial Results

(CNSX:PSE.CN),(Boerse Frankfurt – Freiverkehr:PNX),(CNSX:PSE), TORONTO, July 02, 2025 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (“Pasinex” or the “Company”) today announced financial results for the year ended December 31, 2024, and the first quarter ended March 31, 2025. The financial statements, management's discussion and analysis (MD&A), and related certifications are available on

Amplify ETFs Declares June Income Distributions for Bitcoin Option Income ETFs

(CBOE:BAGY),(CBOE:BITY), CHICAGO, July 02, 2025 (GLOBE NEWSWIRE) — Amplify ETFs announces June income distribution for its Bitcoin* option income ETFs, BITY and BAGY. ETF Name Ticker DistributionRate1 Amount perShare DistributionFrequency 30 DaySEC Yield1 Amplify Bitcoin Max Income Covered Call ETF BAGY 30.66% $1.41350 Monthly 3.27% Amplify Bitcoin 2% Monthly Option Income ETF BITY 24.40% $1.13000

Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement

(NYSE MKT:CHRO),(NYSE:PTHS),(NASDAQ:LGND), The combined company plans to launch ZELSUVMI(TM) for the treatment of molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, the combined company closed on a $50.1 million equity private placement Combined company will operate under the name “Pelthos Therapeutics Inc.” and will trade on the NYSE American exchange

Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism

(NASDAQ:STTK), AUSTIN, TX and DURHAM, NC, July 02, 2025 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-related diseases, today announced that company management will participate in a DR3/TL1A focused

Water Ways Technologies Enters Strategic Partnership for Exclusive Tomato Hybrid Development for Vertical Farming

(TSX-V:WWT),(Frankfurt:WWT), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 02, 2025 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSX-V: WWT) (“Water Ways” or the “Company“), a leading provider of advanced agricultural technologies in North America, is pleased to announce that it has entered into a strategic Tomato Seed

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models

(NASDAQ:TNXP), Combination treatment of mTNX-1700 (mTFF2-MSA fusion protein) with anti-PD1 antibody was associated with increased survival and decreased metastases in animal models of gastric cancer relative to anti-PD1 treatment alone mTNX-1700 treatment was associated with activation of cancer-killing CD8+ T Cells and limiting neutrophil-mediated immune evasion TNX-1700 (hTFF2-HSA fusion protein) is in preclinical development for

Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics

(NasdaqGM:LGND),(NYSE MKT:PTHS), Pelthos plans to launch ZELSUVMI(TM) for the treatment of Molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, Ligand has invested $18 million in the combined company and is entitled to a 13% royalty on worldwide sales of ZELSUVMI Pelthos will commence trading on the NYSE American exchange under

Cipher Mining Surpasses Hashrate Growth Forecasts at Black Pearl and Announces June 2025 Operational Update

(NASDAQ:CIFR),(NASDAQ:CIFRW), NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today announced that Phase I of Black Pearl is now delivering ~3.4 EH/s of self-mining capacity, exceeding the Company's prior guidance of 2.5 EH/s for the second quarter of 2025. Hashrate will continue to increase at the site

Scroll to Top